Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.04

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.04, versus $0.09 reported last year. Revenue for the quarter came in at $7.4 million, versus $8.9 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• JPMorgan Upgrades Meituan Dianping (3690:HK) (MPNGF) to Overweight
• Baird Upgrades Titan Machinery (TITN) to Outperform